3.3 Controlled Substance Prescriptions (Schedules II-V) Requirements

3.3 Controlled Substance Prescriptions (Schedules II-V) Requirements

Prescriptions for controlled substances represent the highest-risk regulatory domain in pharmacy jurisprudence. In Virginia, dispensing controlled substances requires navigating both the federal Controlled Substances Act (CSA, 21 U.S.C. § 801 et seq.) and Title 21 of the Code of Federal Regulations (21 CFR Part 1306), as well as the Virginia Drug Control Act (Va. Code § 54.1-3400 et seq.) and the regulations of the Virginia Board of Pharmacy (18VAC110-20).

Where federal and state laws diverge, the stricter standard always governs. Pharmacists must possess flawless command of controlled substance validity limits, refill prohibitions, and the precise boundaries of allowable pharmacist modifications.

---

Schedule II Prescriptions: Core Formalities & The Zero-Refill Rule

Schedule II substances (e.g., oxycodone, hydrocodone, fentanyl, morphine, methadone, amphetamine mixed salts, methylphenidate) possess a high potential for abuse, severe psychological or physical dependence, and accepted medical use in the United States.

Strict Statutory Rules for Schedule II

1. Zero Refills: Under federal law (21 CFR § 1306.05) and Virginia law (Va. Code § 54.1-3408.01), no refills may ever be authorized or dispensed for a Schedule II controlled substance. If a prescriber writes "Refill x 1" or "Refill PRN" on a Schedule II prescription, that refill notation is legally void and of no legal effect.
2. Valid Formats: Schedule II prescriptions must be transmitted as an electronic prescription (EPCS) meeting DEA security standards, or presented as a written paper prescription bearing the manual ink signature of the practitioner. Stamped signatures, pre-printed signatures, or unauthenticated digital signature images on paper are strictly illegal and invalid.
3. Virginia Expiration Window: While federal law does not specify an expiration date for Schedule II prescriptions, Virginia Board of Pharmacy regulation 18VAC110-20-280 dictates that Schedule II prescriptions expire exactly 6 months from the date of issuance. A Schedule II prescription presented 6 months and 1 day after issuance is legally expired and cannot be dispensed under any circumstance.

---

Multiple Schedule II Prescriptions on the Same Day (§ 1306.12)

Under federal regulation 21 CFR § 1306.12 and Virginia law, an individual practitioner may issue multiple Schedule II prescriptions on a single office visit to provide a patient with sequential supplies of medication. However, this practice is subject to strict statutory guardrails:

• 90-Day Cumulative Supply Limit: The total quantity authorized across all sequential prescriptions cannot exceed a 90-day supply.
• True Date of Issuance: Every prescription in the series must be dated with the actual calendar date on which it was issued (the day the prescriber physically signs it). Post-dating is strictly prohibited by federal and Virginia law.
• Earliest Fill Date Notation: Each sequential prescription (except the first, if intended to be filled immediately) must contain an explicit instruction indicating the earliest date on which the pharmacy may dispense the medication, formatted as:

  "Do not fill before [Date]" or "Earliest fill date: [Date]"

• Legitimate Medical Purpose: The prescriber must conclude that issuing sequential prescriptions serves a bona fide therapeutic purpose and does not create an undue risk of diversion or abuse.

Multiple Schedule II Prescriptions Scenario:
Patient Visit Date: September 4, 2026
Rx 1: Adderall 20 mg #30 -> Date of Issue: September 4, 2026 (Fill immediately)
Rx 2: Adderall 20 mg #30 -> Date of Issue: September 4, 2026 | "Do not fill before October 4, 2026"
Rx 3: Adderall 20 mg #30 -> Date of Issue: September 4, 2026 | "Do not fill before November 3, 2026"
Total Supply: 90 days | Post-Dating: NONE (All bear true date of Sept 4, 2026)

---

Pharmacist Permitted vs. Prohibited Modifications on Schedule II Orders

A critical topic on the Virginia MPJE is what a pharmacist may alter, add, or clarify on a Schedule II prescription when an error or omission occurs. Under official guidance from the Virginia Board of Pharmacy and DEA policy, modifications are strictly divided into permitted and non-modifiable categories:

What a Pharmacist CAN Modify (After Direct Prescriber Consultation)

Following direct verbal consultation with and authorization from the prescribing practitioner, a pharmacist may modify or add:

1. Dosage Form (e.g., changing from capsules to tablets of identical strength);
2. Drug Strength (e.g., dispensing two 5 mg tablets in place of one 10 mg tablet if unavailable);
3. Drug Quantity (e.g., adjusting quantity to match a revised dosing schedule or duration);
4. Directions for Use (clarifying frequency, administration route, or timing);
5. Date of Issuance (correcting an inadvertent clerical error, such as writing the previous year in January, provided the true issue date is verified); and
6. Patient Address (may be added or updated directly from pharmacy records or verified with the patient without contacting the prescriber).

What a Pharmacist CAN NEVER Change or Add

Under no circumstances may a pharmacist alter, add, or modify:

1. The Patient's Legal Name (a prescription with the wrong patient name is void; a new prescription is required);
2. The Drug Prescribed (Chemical Entity) (the pharmacist cannot switch from oxycodone to hydromorphone; generic substitution according to Virginia law is permitted, but the active molecular entity cannot be altered without a new prescription); or
3. The Prescriber's Signature (an unsigned paper prescription cannot be validated via verbal authorization; the physical manual signature must be present).

Documentation Rule: Any permitted change to a Schedule II prescription must be documented on the face or reverse of the prescription (or in the electronic record), detailing the date, time, consultation specifics, prescriber's approval, and the pharmacist's signature or initials.

---

Schedules III, IV, and V Controlled Substances Requirements

Controlled substances in Schedules III through V are subject to distinct statutory rules governing validity, refills, and oral transmission:

Schedule III and IV Refill Limits

Under Va. Code § 54.1-3410 and federal CSA rules, a prescription for a Schedule III or IV controlled substance (e.g., buprenorphine/naloxone, testosterone, zolpidem, alprazolam, clonazepam) expires 6 months from the date of issue and may be refilled a maximum of 5 times. If a prescriber writes "Refill x 8" on an alprazolam prescription, the pharmacist can only dispense a maximum of 5 refills within the 6-month statutory window.

Schedule V Validity in Virginia

Under federal CSA rules, Schedule V prescriptions (e.g., pregabalin, lacosamide, diphenoxylate/atropine) may technically be refilled as authorized for up to 1 year. However, Virginia law is stricter: under Va. Code § 54.1-3410, Schedule V prescriptions in Virginia expire 6 months from the date of issuance. Refills may be dispensed as authorized, but only within that 6-month window.

---

Emergency Oral Schedule II Dispensing Rules

In a bona fide medical emergency, an oral prescription for a Schedule II drug may be accepted under 21 CFR § 1306.11(d) and Va. Code § 54.1-3410, provided strict criteria are met:

1. Emergency Criteria: Immediate administration is necessary for proper treatment, no alternative non-C-II medication is available, and it is not reasonably possible for the prescriber to present a written or electronic prescription prior to dispensing.
2. Quantity Restriction: The quantity dispensed must be limited strictly to the amount necessary to treat the patient during the emergency period (not a standard 30-day supply).
3. Immediate Reduction to Writing: The pharmacist must immediately transcribe the order with all required C-II elements except the manual signature.
4. The 7-Day Rule: Within 7 calendar days of the oral authorization, the prescriber must deliver or postmark a covering written or compliant electronic prescription for the emergency quantity. The prescription must bear the notation: "Authorization for Emergency Dispensing" and state the date of the oral order.
5. Mandatory Reporting: If the prescriber fails to provide the covering prescription within 7 days, the pharmacist must notify the DEA and the Virginia Board of Pharmacy. Failure to report revokes the pharmacy's legal authority to dispense without a written order.